AZoLifeSciences on MSN23h
Bispecific antibodies for SARS-CoV-2 variant neutralizationBispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
The following is a summary of “Association of KCNJ11 E23K/rs5219 Gene Polymorphism with Type 2 Diabetes and Diabetes-Related ...
DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers have long struggled to understand how cancer cells hijack one of these ...
The DNA polymerase market in the United States is poised for significant expansion, with projections indicating a market size of USD 148.7 million by 2025 and a compound annual growth rate (CAGR) of 5 ...
Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, a class of targeted anticancer therapies, prevent genetic ...
Rapid syndromic polymerase chain reaction testing in the ICU vs standard-of-care testing improves antibiotic stewardship but ...
The DNA polymerase market in South Korea is witnessing significant expansion, driven by rapid advancements in biotechnology, increased investment in genomic research, and the rising adoption of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback